These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9198065)

  • 21. Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects.
    Gleave ME; Goldenberg SL; Chin JL; Warner J; Saad F; Klotz LH; Jewett M; Kassabian V; Chetner M; Dupont C; Van Rensselaer S;
    J Urol; 2001 Aug; 166(2):500-6; discussion 506-7. PubMed ID: 11458055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial comment.
    Mearini L
    J Urol; 2012 Jun; 187(6):2166-7. PubMed ID: 22503017
    [No Abstract]   [Full Text] [Related]  

  • 23. One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men.
    Almeida OP; Waterreus A; Spry N; Flicker L; Martins RN
    Psychoneuroendocrinology; 2004 Sep; 29(8):1071-81. PubMed ID: 15219659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STAMPEDE trial and patients with non-metastatic prostate cancer.
    Gandaglia G; Fossati N; Suardi N; Montorsi F; Briganti A
    Lancet; 2016 Jul; 388(10041):234-5. PubMed ID: 27479564
    [No Abstract]   [Full Text] [Related]  

  • 25. Defining new standards of care for men with prostate cancer.
    Scher HI
    Lancet; 2016 Mar; 387(10024):1135-7. PubMed ID: 27025318
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of neoadjuvant hormonal therapy on prostate biopsy results after (125)I and (103)Pd seed implantation.
    Stone NN; Stock RG; Unger P
    Mol Urol; 2000; 4(3):163-8;discussion 169-70. PubMed ID: 11062370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer: Changing standard of care in hormone-sensitive disease.
    Thoma C
    Nat Rev Urol; 2016 Feb; 13(2):61. PubMed ID: 26787390
    [No Abstract]   [Full Text] [Related]  

  • 28. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.
    Chang A; Yeap B; Davis T; Blum R; Hahn R; Khanna O; Fisher H; Rosenthal J; Witte R; Schinella R; Trump D
    J Clin Oncol; 1996 Aug; 14(8):2250-7. PubMed ID: 8708714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete androgen blockade versus chemical castration in advanced prostatic cancer: analysis of an Italian multicentre study. Italian Leuprorelin Group.
    Bono AV; DiSilverio F; Robustelli della Cuna G; Benvenuti C; Brausi M; Ferrari P; Gibba A; Galli L
    Urol Int; 1998; 60 Suppl 1():18-24. PubMed ID: 9563140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Finasteride plus flutamide for prostatic carcinoma.
    Sandhu SS; Matveev VB; Kaisary AV
    Br J Urol; 1997 Aug; 80(2):360. PubMed ID: 9284230
    [No Abstract]   [Full Text] [Related]  

  • 31. Flutamide-induced toxic hepatitis. Potential utility of ursodeoxycholic acid administration in toxic hepatitis.
    Cicognani C; Malavolti M; Morselli-Labate AM; Sama C; Barbara L
    Dig Dis Sci; 1996 Nov; 41(11):2219-21. PubMed ID: 8943975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal ablation as effective therapy for carcinomatous meningitis from prostatic carcinoma.
    Mencel PJ; DeAngelis LM; Motzer RJ
    Cancer; 1994 Apr; 73(7):1892-4. PubMed ID: 8137217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined low-dose flutamide plus finasteride vs low-dose flutamide monotherapy for recurrent prostate cancer: a comparative analysis of two phase II trials with a long-term follow-up.
    Bañez LL; Blake GW; McLeod DG; Crawford ED; Moul JW
    BJU Int; 2009 Aug; 104(3):310-4. PubMed ID: 19239458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal.
    Dawson N; Figg WD; Brawley OW; Bergan R; Cooper MR; Senderowicz A; Headlee D; Steinberg SM; Sutherland M; Patronas N; Sausville E; Linehan WM; Reed E; Sartor O
    Clin Cancer Res; 1998 Jan; 4(1):37-44. PubMed ID: 9516950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leuprorelin 1-month depot as neoadjuvant therapy for prostate cancer. Takeda NHT Italian Group.
    Prezioso D; Lotti T; Montironi R; Polito M
    Urol Int; 1998; 60 Suppl 2():11-7; discussion 35. PubMed ID: 9607553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cabazitaxel for castration-resistant prostate cancer.
    Froehner M; Wirth MP
    Lancet; 2011 Jan; 377(9760):121-2; author reply 122-3. PubMed ID: 21215875
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of an LH-RH analogue (Goeserelin acetate, 'Zoladex') with combined androgen blockade in advanced prostate cancer: final survival results of an international multicentre randomized-trial. International Prostate Cancer Study Group.
    Tyrrell CJ; Altwein JE; Klippel F; Jurincic-Winkler C; Varenhorst E; Lunglmayr G; Boccardo F; Holdaway IM; Haefliger JM; Jordaan JP
    Eur Urol; 2000 Feb; 37(2):205-11. PubMed ID: 10705200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAMPEDE trial and patients with non-metastatic prostate cancer - Authors' reply.
    James ND; Sydes MR; Clarke NW; Mason MD; Parmar MK
    Lancet; 2016 Jul; 388(10041):235-6. PubMed ID: 27479566
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of nomogram to non-steroidal antiandrogen sequential alternation in prostate cancer for predictive model.
    Kamiya N; Suzuki H; Nishimura K; Fujii M; Okegawa T; Matsuda T; Morita T; Takihana Y; Ozono S; Namiki M; Matsubara A; Ichikawa T; Miki T
    Jpn J Clin Oncol; 2014 Mar; 44(3):263-9. PubMed ID: 24516203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of combined endocrine therapy on prostate and testis].
    Kong X; Zeng L; Xia T; Wang J; Mi P; Na Y; Xue Z; Pan B; Hao J; Gu F; Guo Y
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):231-4. PubMed ID: 11829828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.